BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22475637)

  • 21. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
    Arcaini L; Burcheri S; Rossi A; Passamonti F; Paulli M; Boveri E; Brusamolino E; Orlandi E; Molteni A; Pulsoni A; Cox MC; Orsucci L; Fabbri A; Frezzato M; Voso MT; Zaja F; Montanari F; Pascutto C; Morra E; Cortelazzo S; Lazzarino M
    Oncologist; 2006 Mar; 11(3):285-91. PubMed ID: 16549813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative analysis of lymphomas involving Waldeyer's ring and the nasal cavity and paranasal sinuses.
    Robbins KT; Kong JS; Fuller LM; Goepfert H
    J Otolaryngol; 1985 Feb; 14(1):7-13. PubMed ID: 4068097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary gastric lymphoma of the MALT type. The current knowledge on its etiology, therapy and prognosis].
    Fischbach W; Wilms K
    Strahlenther Onkol; 1995 Oct; 171(10):549-53. PubMed ID: 8571173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally invasive procedure for accurate diagnosis of mucosa-associated lymphoid tissue lymphoma of the head and neck.
    Orita Y; Sato Y; Kondo E; Ishihara H; Hirai H; Hanakawa H; Onoda T; Igawa T; Saito R; Nishizaki K; Yoshino T
    Jpn J Clin Oncol; 2012 Apr; 42(4):325-30. PubMed ID: 22345703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoid lesions of the head and neck: a model of lymphocyte homing and lymphomagenesis.
    Jaffe ES
    Mod Pathol; 2002 Mar; 15(3):255-63. PubMed ID: 11904341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Malignant lymphoma of the thyroid].
    Ohye H; Fukata S; Hirokawa M
    Nihon Rinsho; 2007 Nov; 65(11):2092-8. PubMed ID: 18018576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
    Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM
    Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Hodgkin lymphoma of the Waldeyer's ring: clinicopathologic and therapeutic issues.
    Laskar S; Mohindra P; Gupta S; Shet T; Muckaden MA
    Leuk Lymphoma; 2008 Dec; 49(12):2263-71. PubMed ID: 19052973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoid proliferations of the salivary glands.
    Harris NL
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S94-103. PubMed ID: 9894474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of radiotherapy in stage I to II extranodal non-Hodgkin's lymphoma of the head and neck.
    Kuten A; Ben-Shahar M; Epelbaum R; Haim N; Cohen Y; Robinson E
    Strahlenther Onkol; 1989 Aug; 165(8):578-83. PubMed ID: 2772814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-Hodgkin's lymphoma. Extranodal localizations in the head and neck. Clinical and therapeutic evaluations].
    Maurizi Enrici R; Busi E; Guglielmi C; Martelli M; Pizzi C; Tombolini V; Biagini C
    Radiol Med; 1987; 74(1-2):103-8. PubMed ID: 3615966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: a potential role for parotid-sparing techniques?
    Chang DT; Amdur RJ; Pacholke H; Mendenhall NP; Morris CG; Byer GA; Olivier KR
    Am J Clin Oncol; 2009 Apr; 32(2):145-9. PubMed ID: 19307951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [MALT-lymphoma--conservative therapy].
    Fischbach W
    Praxis (Bern 1994); 1996 Nov; 85(45):1455-8. PubMed ID: 8975357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosa-associated lymphoid tissue lymphoma.
    Isaacson PG
    Semin Hematol; 1999 Apr; 36(2):139-47. PubMed ID: 10319382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Non-gastric mucosa-associated lymphoid tissue (MALT) lymphomas: analysis of 14 patients].
    Ferrer A; López-Guillermo A; Bosch F; Montoto S; Hernández-Boluda JC; Camós M; Miquel R; Campo E; Montserrat E
    Med Clin (Barc); 1999 May; 112(15):577-80. PubMed ID: 10365385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary thyroid lymphomas.
    Avenia N
    G Chir; 2009 May; 30(5):197-200. PubMed ID: 19505411
    [No Abstract]   [Full Text] [Related]  

  • 40. [The diagnosis and treatment of primary thyroid lymphoma].
    Liang P; Wang S; Chen KB; Li M; Liu Y; Li S; Pan YW; Zhang YX; Jiang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):313-6. PubMed ID: 27095732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.